The implementation of non-invasive prenatal testing (NIPT) in the Netherlands

Area of Science:

• Reproductive Health
• Genetics
• Public Health Policy

Background:

• Prenatal screening in the Netherlands aims to enhance reproductive choices.
• Midwives provide counseling on available screening options, emphasizing informed choice.
• The Dutch government prioritizes women's opinions on screening.

Purpose of the Study:

• To describe the implementation and perception of genome-wide non-invasive prenatal testing (NIPT) in the Netherlands.
• To analyze the uptake of NIPT as a first-tier screening for aneuploidies.
• To understand how this screening offer aligns with the traditionally cautious Dutch system.

Main Methods:

• NIPT (cell-free DNA) offered as a first-tier screening for genome-wide aneuploidies since 2017.
• Screening provided at a cost of 175 Euros.
• Counseling provided by trained midwives to ensure informed choice.

Main Results:

• NIPT uptake is approximately 50%.
• The introduction of NIPT is considered unconventional within the Dutch system.
• Focus on informed choice and women's reactions to screening options.

Conclusions:

• The Dutch system has adopted NIPT for genome-wide aneuploidies, impacting reproductive choices.
• The 50% uptake suggests a complex reception of this advanced screening technology.
• Further analysis is needed to understand the long-term implications of this unconventional screening offer.